People: DURECT Corp (DRRX.O)

DRRX.O on Consolidated Issue listed on NASDAQ Global Market

2.44USD
22 May 2015
Change (% chg)

$0.10 (+4.27%)
Prev Close
$2.34
Open
$2.34
Day's High
$2.44
Day's Low
$2.30
Volume
323,425
Avg. Vol
851,944
52-wk High
$2.65
52-wk Low
$0.68

Search Stocks

Benito, Simon 

Mr. Simon X. Benito is an Independent Director of DURECT Corporation, since April 2005. Mr. Benito is currently a director and chairman of the Audit Committee of Inovio Pharmaceuticals Corporation, a biomedical company. From 1974 to 1999, Mr. Benito held various positions at Merck & Co Inc. including Senior Vice President, Vaccine Division from 1996 to 1999, Executive Vice President, Merck-Medco Managed Care from 1994 to 1996 and Executive Director and Vice President, Merck Human Health, Japan from 1986-1993. Mr. Benito was a Fellow of the Institute of Chartered Accountants in England and Wales from 1969 to 1999 until his retirement from Merck. Mr. Benito’s pharmaceutical industry experience as relates to executive management, corporate transactions and international operations as well as his financial and accounting expertise are among the qualifications he brings to the Board and his service as a Director of the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Felix Theeuwes

747,375

James Brown

955,726

Matthew Hogan

633,749

Judy Joice

545,972

David Hoffmann

--

Simon Benito

--
As Of  30 Dec 2014
Search Stocks